The core antigen of hepatitis B virus as a carrier for immunogenic peptides

Biological Chemistry

Volumn 380, Issue 3, 1999, Pages 277-283

  Murray, Kenneth ^a   Shiau, Ai Li ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Fusion proteins; Immune response; Nucleocapsids; Peptide antigens

Indexed keywords

HEPATITIS B CORE ANTIGEN; PEPTIDE;

ESCHERICHIA COLI; HEPATITIS B VIRUS; IMMUNOGENICITY; PRIORITY JOURNAL; REVIEW; VIRUS ASSEMBLY; VIRUS NUCLEOCAPSID; VIRUS PARTICLE;

ESCHERICHIA COLI; HEPATITIS B VIRUS;

EID: 0033042257     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.038     Document Type: Review

References (37)

1. Ashton-Rickardt, P.G., and Murray, K. (1989). Mutations that change the immunological subtype of hepatitis B virus surface antigen and distinguish between antigenic and immunogenic determination. J. Med. Virol. 29, 204-214.
2. Bancroft, W.H., Mundon, F.K., and Russell, P.K. (1972). Detection of additional antigenic determinants of hepatitis B antigen. J. Immunol. 109, 842-848.
3. Borisova, G.P., Berzins, I., Pushko, P.M., Pumpens, P., Gren, E.J., Tsibinogin, V.V., Loseva, V., Ose, V., Ulrich, R., Siakkou, H., and Rosenthal, H.A. (1989). Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface. FEBS Lett. 259, 121-124.
4. Borisova, G., Arya, B., Dislers, A., Borschukova, O., Tsibinogin, V., Skrastina, D., Eldarov, M.A., Pumpens, P., Skryavin, K.G., and Grens, E. (1993). Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B surface antigen. J. Virol. 67, 3696-3701.
5. Böttcher, B., Wynne, S.A., and Crowther, R.A. (1997). Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 386, 88-91.
6. Broome, S., and Gilbert, W. (1978). Immunological screening method to detect specific translation products. Proc. Natl. Acad. Sci. USA 75, 2746-2749.
7. Burrell, C.J., Leadbetter, G., Black, S.H., and Hunter, W.M. (1978). Rapid detection of hepatitis B surface antigen by double antibody radioimmunoassay. J. Med. Virol. 3, 19-26.
8. Burrell, C.J., MacKay, P., Greenaway, P.J., Hofschneider, P.H., and Murray, K. (1979). Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature 279, 43-47
9. Carman, W.F., Zanetti, A.R., Karayiannis, P., Waters, J., Manzillo, G., Tanzi, E., Zuckerman, A.J., and Thomas, H.C. (1990). Vaccine-induced escape mutant of hepatitis B virus. Lancet 336, 325-329.
10. Clarke, B.E., Newton, S.E., Carroll, A.R., Francis, M.J., Appleyard, G., Syred, A.D., Highfield, P.E., Rowlands, D.J., and Brown, F. (1987). Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 330, 381-384.
11. Cohen, B.J., and Richmond, J.E. (1982). Electron microscopy of hepatitis B core antigen synthesized in E. coli. Nature 296, 677-678.
12. Conway, V.F., Cheng, N., Zlotnick, A., Wingfield, P.T., Stahl, S.J., and Steven, A.C. (1997). Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature 386, 91-94.
13. Couroucé-Pauty, A.-M., and Holland, P.V. (1978). Summary of Workshop A2: HBsAg and its subtypes. In: Viral Hepatitis. G.N. Vyas, S.N. Cohen and R. Schmid, eds. (Philadelphia, USA: Franklin Institute Press), pp. 649-654.
14. Iwarson, S., Tabor, E., Thomas, H.C., Snoy, P., and Gerety, R.J. (1985). Protection against hepatitis B virus infection by immunization with hepatitis B core antigen. Gastroenterol. 88, 763-767.
15. Le Bouvier, G.L. (1971). The heterogeneity of Australia antigen. J. Infect. Dis. 123, 671-675.
16. MacKay, P., Lees, J., and Murray, K. (1981). The conversion of hepatitis B core antigen synthesised in E. coli into e antigen. J. Med. Virol. 8, 237-243.
17. Magnius, L.O., and Espmark, J.A. (1972). New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J. Immunol. 109, 1017-1021.
18. McAleer, W.J., Buynak, E.B., Maigetter, R.S., Wampler, D.E., Miller, W.J., and Hilleman, M.R. (1984). Human hepatitis B vaccine from recombinant yeast. Nature 307, 178-180.
19. McMichael, A.J., Gotch, F.M., Noble, G.R., and Beare, P.A.S. (1983). Cytoskeleton T-cell immunity to influenza. N. Engl. J. Med. 309, 13-17.
20. Milich, D.R., McLachlan, A., Thornton, G.B., and Hughes, J.L. (1987). Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 329, 547-549.
21. Mondelli, M., Miele Vergani, G., Alberti, A., Vergani, D., Portmann, B., Eddleston, A.L.W.F., and Williams, R. (1982). Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J. Immunol. 129, 2773-2778.
22. Murray, K. (1987). The Leeuwenhoek Lecture, 1985: A molecular biologist's view of viral hepatitis. Proc. R. Soc. Lond. B. 230, 107-146.
23. Murray, K. (1988). Application of recombinant DNA techniques in the development of viral vaccines. Vaccine 6, 164-174.
24. Murray, K., Bruce, S.A., Hinnen, A., Wingfield, P., van Eerd, P.M.C.A., de Reus, A., and Schellekens, H. (1984). Hepatitis B virus antigens made in microbial cells immunise against viral infection. EMBO J. 3, 645-650.
25. Murray, K., Bruce, S.A., Wingfield, P., van Eerd, P., de Reus, A., and Schellekens, H.(1987). Protective immunisation against hepatitis B with an internal antigen of the virus. J. Med. Virol. 23 101-107.
26. Pasek, M., Goto, T., Gilbert, W., Zink, B., Schaller, H., MacKay, P., Leadbetter, G., and Murray, K. (1979). Hepatitis B virus genes and their expression in E. coli. Nature 282, 575-579.
27. Salfeld, J. Pfaff, E., Noah, M., and Schaller, H. (1989). Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J. Virol. 63, 798-808.
28. Schödel, F., Moriarty, A.M., Peterson, D.L., Zheng, J., Hughes, J.L., Will, H., Leturcq, D.J., McGee, J.S., and Milich, D.R. (1992). The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J. Virol. 66, 106-114.
29. Shiau, A.L. (1993). Immunological aspects of hepatitis B virus core antigen and its derivatives. PhD thesis, University of Edinburgh, UK.
30. Shiau, A.L., and Murray, K. (1997). Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the nature surface antigen. J. Virol. 51, 159-166.
31. Stahl, S.J., and Murray, K. (1989). Immunogenicity of peptide fusions to hepatitis B virus core antigens. Proc. Natl. Acad. Sci. USA 86, 6283-6287.
32. Stahl, S., MacKay, P., Magazin, M., Bruce, S.A., and Murray, K. (1982). Hepatitis B virus core antigen. Synthesis in Escherichia coli and application in diagnosis. Proc. Natl. Acad. Sci. USA 79, 1606-1610.
33. Szmuness, W., Stevens, C.E., Harley, E.J., Zang, E.A., Oleszko, W.R., William, D.C., et al. (1980). Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N. Engl. J. Med. 203, 833-841.
34. Tiollais, P., Pourcel, C., and Dejean, A. (1985). The hepatitis B virus. Nature 317, 489-495.
35. Ulrich, R., Nassal, M., Meisel, H., and Krüger, D.H. (1998). Core particles of hepatitis B virus as carrier for foreign epitopes. Adv. Virus Res. 50, 141-182.
36. Yewdell, J.W., Bennink, J.R., Smith, G.L., and Moss, B. (1985). Influenza A virus nucleoprotein is a major target antigen for cross reactive anti-influenza A virus cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 82, 1785-1789.
37. Yoshikawa, A., Tanaka, T., Hoshi, Y., Kato, N., Tachibana, K., Iizuka, H., Machida, A., Okamoto, H., Yamasaki, M., Miyakawa, Y., and Mayumi, M. (1993). Chimeric hepatitis B virus core particles with parts of copies of the hepatitis C virus core protein. J. Virol. 67, 6064-6070.